
KALIA HEALTH
OperatingKalia Health, Inc
Healthcare · Technology · Chapel Hill, NC · Founded 2018
Bringing healthcare home
Financials
FY2022–FY2023 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
4 people
Denali is a biomedical engineer and global health researcher specializing in female sexual and reproductive health. She holds degrees from UC San Diego, Duke University, and UNC Chapel Hill & NC State University. Her work includes developing a portable diagnostic tool for cervical cancer and long-acting drug delivery systems for sexually transmitted diseases and contraception.

Happy is a biomedical engineer and global health researcher with degrees from Boston University and Duke University. She has developed and evaluated medical devices for low-resource settings, including mHealth platforms, lateral flow technology for brain injury, and ultrasound coupling media. Suvomita Happy Ghosh will be providing Form C sign-off as the Company's Principal Accounting Officer.

Jamison is an award-winning healthcare executive with over 15 years of experience in innovation and business strategy. He has worked with the Alzheimer Institute of America and Roche Diagnostics, managing commercial activities across 20 countries. Jamison excels in performance management and has a vast international network of key stakeholders.

Simon Bentley is a British born entreprenuer. In 2010 he relocated from UK to the UAE. In 2015 he started Gander.ae - a production company - in the UAE. In 2018 Simon turned his attention to the Real Estate market and began purchasing properties in Dubai, UAE to leverage it's growth potential and favorable banking terms. During Covid-19 he significantly increased his porfolio in Dubai. In 2023 Simon began offloading the real estate at and average of +500% gains and divesting the returns in to other industries.
Names and titles as disclosed on StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 2 annual reports (FY2024–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.